Trial Profile
An open-label study to evaluate contraceptive efficacy and safety of the transdermal contraceptive system of 17d norgestimate and ethinyl estradiol [ethinylestradiol/norelgestromin] with the oral contraceptive Mercilon [ethinylestradiol/desogestrel]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/desogestrel (Primary) ; Ethinylestradiol/norelgestromin (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 27 Nov 2005 New trial record.